<DOC>
	<DOCNO>NCT02247427</DOCNO>
	<brief_summary>The purpose study determine clinical outcome related deactivation Cardiac Resynchronization Therapy device subject super response .</brief_summary>
	<brief_title>Clinical Outcomes Related Cardiac Resynchronization Therapy Deactivation Super Responders</brief_title>
	<detailed_description />
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>super response Cardiac Resynchronization Therapy near normal Left ventricular ejection fraction &gt; 99 % pace &lt; 99 % pace atrial fibrillation ischemic cardiomyopathy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Super responder</keyword>
</DOC>